Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Poorly Regulated Type 1 Diabetes
NCT01612468Phase 4Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Jun 2012
- Primary completion
- Feb 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by Steno Diabetes Center Copenhagen. Started Jun 2012; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01612468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612468.